CUTR - Cutera Synchrony team up for financing options for patients using acne device AviClear

Cutera (NASDAQ:CUTR) and Synchrony (NYSE:SYF) entered an exclusive partnership to expand patient financing options to dermatology practices in the U.S. The companies said that dermatologists offering AviClear, Cutera’s device to treat acne, will have the option to accept Synchrony’s CareCredit credit card providing flexible financing options. The companies noted that AviClear is expected to be made available to physicians in the U.S. over 2022.

For further details see:

Cutera, Synchrony team up for financing options for patients using acne device AviClear